Recent News

Phase I clinical trial shows some promise for investigational drug for melanoma

Phase I clinical trial shows some promise for investigational drug for melanoma

Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.

Phase I clinical trial shows some promise for investigational drug for melanoma - Read More…

American Society of Clinical Oncology's annual report features UNC Lineberger research

American Society of Clinical Oncology's annual report features UNC Lineberger research

Research findings by Ethan Basch, MD, MSc, and Ronald C. Chen, MD, MPH, were cited as being among the most impactful advances and policy developments in cancer in 2017.

American Society of Clinical Oncology's annual report features UNC Lineberger research - Read More…

Patient research advocates help scientists-in-training communicate findings more effectively

Patient research advocates help scientists-in-training communicate findings more effectively

UNC Lineberger’s Patient Research Advocacy Group will help scientists and trainees to consider the patient perspective when conducting and presenting their research.

Patient research advocates help scientists-in-training communicate findings more effectively - Read More…

Researchers define structure, function of enzyme key to blood cancers

Researchers define structure, function of enzyme key to blood cancers

In the journal Nature, UNC Lineberger's Greg Wang, PhD, and colleagues reported findings about the structure and function of the DNMT3A enzyme complex, which helps control gene expression.

Researchers define structure, function of enzyme key to blood cancers - Read More…